Egyptian Board Gastroenterology & Hepatology
Egyptian Board — Gastroenterology & Hepatology (Part 1 & 2)
Quick practiceEnglish
Exam overviewPractice session
A 49-year-old treatment-naive man with chronic hepatitis C virus (HCV) infection is evaluated. He has compensated liver disease without cirrhosis (transient elastography stiffness 6.2 kPa). Viral genotyping is not immediately available. Which oral pangenotypic direct-acting antiviral (DAA) regimen and treatment duration is recommended by WHO and EASL guidelines?
Loading your practice session…